Literature DB >> 16311892

Genetic interaction between two apolipoprotein E receptors increases Alzheimer's disease risk.

Eloy Rodríguez, Ignacio Mateo, Javier Llorca, Coro Sánchez-Quintana, Jon Infante, José Berciano, Onofre Combarros.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16311892     DOI： 10.1007/s00415-005-0063-1

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  13 in total

Review 1.  Apolipoprotein E receptors: linking brain development and Alzheimer's disease.

Authors:  J Herz; U Beffert
Journal:  Nat Rev Neurosci       Date:  2000-10       Impact factor: 34.870

2.  Apolipoprotein E receptor LR11: intersections between neurodegeneration and cholesterol metabolism.

Authors:  Benjamin Wolozin
Journal:  Arch Neurol       Date:  2004-08

3.  Consistency in gene-Alzheimer's disease association studies.

Authors:  Javier Llorca; Trinidad Dierssen-Sotos; Onofre Combarros; José Berciano
Journal:  J Epidemiol Community Health       Date:  2005-01       Impact factor: 3.710

4.  Case-control study and meta-analysis of low density lipoprotein receptor-related protein gene exon 3 polymorphism in Alzheimer's disease.

Authors:  M Sánchez-Guerra; O Combarros; J Infante; J Llorca; J Berciano; A Fontalba; J L Fernández-Luna; N Peña; C Fernández-Viadero
Journal:  Neurosci Lett       Date:  2001-12-04       Impact factor: 3.046

5.  Association study and meta-analysis of low-density lipoprotein receptor related protein in Alzheimer's disease.

Authors:  Antonia Pritchard; Judith Harris; Colin W Pritchard; David St Clair; Helen Lemmon; Jean-Charles Lambert; Marie-Christine Chartier-Harlin; Angela Hayes; Uma Thaker; Takeshi Iwatsubo; David M A Mann; Corinne Lendon
Journal:  Neurosci Lett       Date:  2005-04-21       Impact factor: 3.046

Review 6.  Cholesterol metabolism in the brain.

Authors:  J M Dietschy; S D Turley
Journal:  Curr Opin Lipidol       Date:  2001-04       Impact factor: 4.776

7.  Functional interaction between APOE4 and LDL receptor isoforms in Alzheimer's disease.

Authors:  D Cheng; R Huang; I S Lanham; H M Cathcart; M Howard; E H Corder; S E Poduslo
Journal:  J Med Genet       Date:  2005-02       Impact factor: 6.318

8.  Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway.

Authors:  D E Kang; C U Pietrzik; L Baum; N Chevallier; D E Merriam; M Z Kounnas; S L Wagner; J C Troncoso; C H Kawas; R Katzman; E H Koo
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

9.  Association of the C766T polymorphism of the low-density lipoprotein receptor-related protein gene with Alzheimer's disease.

Authors:  Heike Kölsch; Ursula Ptok; Iman Mohamed; Sandra Schmitz; Marie Luise Rao; Wolfgang Maier; Reinhard Heun
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2003-08-15       Impact factor: 3.568

Review 10.  Alzheimer's disease: the cholesterol connection.

Authors:  Luigi Puglielli; Rudolph E Tanzi; Dora M Kovacs
Journal:  Nat Neurosci       Date:  2003-04       Impact factor: 24.884
View more
  3 in total

1.  Association and interaction analysis of variants in CHRNA5/CHRNA3/CHRNB4 gene cluster with nicotine dependence in African and European Americans.

Authors:  Ming D Li; Qing Xu; Xiang-Yang Lou; Thomas J Payne; Tianhua Niu; Jennie Z Ma
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-04-05       Impact factor: 3.568

2.  Association between LRP1 C766T polymorphism and Alzheimer's disease susceptibility: a meta-analysis.

Authors:  Yun Wang; Shengyuan Liu; Jingjing Wang; Jie Zhang; Yaqiong Hua; Hua Li; Huibiao Tan; Bin Kuai; Biao Wang; Sitong Sheng
Journal:  Sci Rep       Date:  2017-08-16       Impact factor: 4.379

3.  LDLR expression and localization are altered in mouse and human cell culture models of Alzheimer's disease.

Authors:  Jose F Abisambra; Tina Fiorelli; Jaya Padmanabhan; Peter Neame; Inge Wefes; Huntington Potter
Journal:  PLoS One       Date:  2010-01-01       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.